Clarke has over 20 years in aviation leadership, including roles as CCO at Air France-KLM and executives roles at Qantas, Air Canada, and Bluepoint Aviation.
Before marketing MMS as a cure for COVID-19, the Grenons marketed MMS as a miracle cure-all for dozens of other serious diseases and disorders, such as cancer, Alzheimer’s disease, diabetes, HIV/AIDS, and leukemia.